Skip to main content
XtalPi Holdings Limited logo

XtalPi Holdings Limited — Investor Relations & Filings

Ticker · 2228 ISIN · KYG7S12M1051 LEI · 8368004IS42UJ5SVEV76 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 117 across all filing types
Latest filing 2024-06-12 Remuneration Information
Country KY Cayman Islands
Listing HKEX 2228

About XtalPi Holdings Limited

http://www.xtalpi.com

XtalPi Holdings Limited is an innovative research and development platform specializing in accelerating molecular R&D processes. The company provides drug and material science R&D solutions and services to global conglomerates, primarily targeting the biopharmaceutical, material science, and energy/chemical sectors. XtalPi's unique selling proposition is its proprietary technology stack, which integrates quantum physics-based modeling, artificial intelligence (AI) algorithms, and robotics-driven standardized automation. The company operates through business segments that offer modular Drug Discovery Solutions, collaborative R&D services, and an in-house R&D and out-licensing model focused on early-stage drug discovery.

Recent filings

Filing Released Lang Actions
Remuneration Committee - Terms of Reference
Remuneration Information Classification · 95% confidence The document is titled 'Remuneration Committee – Terms of Reference' and details the structure, duties, powers, and procedures of the Remuneration Committee of QuantumPharm Inc. It outlines governance practices related to executive and director remuneration but does not contain actual remuneration figures or compensation details. It is a governance-related document describing committee terms rather than a report on remuneration or compensation itself. Therefore, it fits best under the category of Remuneration Information, which covers reports detailing compensation for top executives and directors, especially when it includes committee terms and governance around remuneration.
2024-06-12 English
Nomination Committee - Terms of Reference
Governance Information Classification · 95% confidence The document is titled 'Nomination Committee – Terms of Reference' and details the structure, membership, duties, meeting procedures, and authority of the Nomination Committee within the company. It focuses on governance aspects such as board composition, director nomination, and committee responsibilities. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related report outlining internal rules and practices of the board committee. Therefore, it fits best under Governance Information (CGR). The document length (6585 characters) supports it being a full report rather than a brief announcement.
2024-06-12 English
Audit Committee - Terms of Reference
Governance Information Classification · 100% confidence The document is titled 'Audit Committee – Terms of Reference' and details the composition, duties, powers, meeting procedures, and authority of the Audit Committee of QuantumPharm Inc. It outlines governance and oversight responsibilities related to financial reporting, risk management, internal controls, and the relationship with external auditors. There are no actual financial statements, audit results, or report data included. Instead, it is a governance document describing the committee's role and functions. This fits the definition of a Governance Information (CGR) filing, which covers internal rules, board structure, and governance practices. The document length is substantial and contains detailed governance policies rather than a report or announcement of a report.
2024-06-12 English
NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled as the Ninth Amended and Restated Memorandum and Articles of Association of QuantumPharm Inc., conditionally adopted by special resolution. It contains detailed company constitutional documents including definitions, company powers, share capital, register of members, and procedural rules. These are governance documents that define the internal rules and structure of the company rather than financial results, management changes, or shareholder meeting materials. There is no indication of financial statements, audit reports, earnings data, or voting results. The document is lengthy (15,000 characters) and is the actual text of the amended articles, not an announcement or summary. Therefore, it fits the category of Governance Information (CGR).
2024-06-12 English
Documents on Display
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2024-06-04 English
GLOBAL OFFERING
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for a global offering of shares by QuantumPharm Inc., including information about the number of shares offered, offer price, application procedures, underwriting arrangements, and regulatory disclaimers. It is clearly an IPO prospectus, which is a type of capital raising document. The text includes detailed offering terms, application instructions, and regulatory compliance statements typical of a capital/financing update related to a public offering. It is not an annual report, earnings release, or any other type of report but rather a document announcing and detailing a capital raising event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual offering document, not just an announcement or a brief summary.
2024-06-04 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.